Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2034804 Target Snapshot

Taste receptor type 2 member 31 · SINGLE PROTEIN · Homo sapiens

22Compounds
71Assays
1Approved Drugs
19.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P59538. Use UniProt P59538 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P59538 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Taste receptor type 2 member 31 as ChEMBL target CHEMBL2034804, mapped to UniProt P59538. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Taste receptor type 2 member 31
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2034804
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P59538
Taste receptor type 2 member 31
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Taste receptor type 2 member 31 is the right protein anchor across sources, using UniProt P59538 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTaste receptor type 2 member 31
UniProt AccessionP59538
Component TypeProtein
Sequence Length309 aa

Taste receptor type 2 member 31

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Taste receptor type 2 member 31, mapped to UniProt P59538. Sequence length is 309 aa.

Mapped IDP59538
Review nameTaste receptor type 2 member 31
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC506.0
EC5013.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL434 8.31 EC50 4.9 Approved
CHEMBL490162 5.7 IC50 2000.0 Preclinical
CHEMBL210692 5.6 IC50 2500.0 Preclinical
CHEMBL448297 5.44 IC50 3600.0 Preclinical
CHEMBL3315351 5.1 IC50 8000.0 Preclinical
CHEMBL487601 4.95 IC50 11300.0 Preclinical
CHEMBL4440983 4.5 EC50 31500.0 Preclinical
CHEMBL4582048 4.5 EC50 31500.0 Preclinical
Distribution

pChEMBL Value Distribution

2
5.0
2
5.5
0
6.0
0
6.5
0
7.0
0
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ISOPROTERENOL
CHEMBL434
Approved 1956
Assay Landscape

Assay Landscape

71
Total Assays
8
Tested Compounds
2
Assay Types
Functional — 69 assays, 8 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 69 8 5.8
Binding — 2 assays, 5 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 5 5.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine